Developer docs
API playgroundTry for free, no card

Search company profiles

Multicare Pharmaceuticals Philippines

Full company profile

uuid000vur1

Namestring
Multicare Pharmaceuticals Philippines
Legal namestring
Multicare Pharmaceuticals Philippines, Inc.
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Multicare Pharmaceuticals Philippines, Inc. is a Makati City-based, privately-held pharmaceutical distributor and license holder serving the Philippine market as a wholly-owned subsidiary of India's Lupin Ltd. (since 2009). It was established in 1998 as a division of Astra Philippines Inc., became independent in 2002 under founder Romeo Sia Sy, and is positioned among the top 5 branded generic companies in the Philippines with 23+ years of operating history.

Its portfolio comprises prescription medicines, over-the-counter (OTC) consumer health products, biosimilars and innovator products across 12+ therapeutic areas: Diabetes, Oncology, Neuroscience, Gastroenterology, Anti-Infectives, Respiratory, Rheumatology, Critical Care, Women's Health, Orthopedic/Pain, Probiotic and Multi-Channel Consumer Health. Representative products include Glaritus (insulin glargine), Lupigliptin/Lupizin (oral antidiabetics), Abingem 1G and Anzol (oncology), Multivent and Neumoterol (respiratory), Albutein and Plasbumin (critical care plasma products), and consumer brands such as Sorbifer Plus, Calvit, Floracap and Tamipro. Manufacturing is not local; the company markets and distributes formulations via Lupin's global network of 15 manufacturing sites and 7 research centers, supplemented by licensing and business development.

The business model is a sales-led, multi-channel branded generics and consumer health franchise. Revenue is generated through one-time product sales across (i) direct field sales to hospitals and healthcare institutions, (ii) channel partnerships with the three major Philippine retail pharmacy chains (Watsons, Rose Pharmacy, Mercury Drug), (iii) government healthcare procurement, and (iv) e-commerce storefronts on Lazada and Shopee for OTC/consumer health. Pricing is not publicly disclosed; prescriber engagement, medical representatives, multi-channel consumer marketing, and Lupin-backed supply reliability are the stated value drivers.

Short descriptiontext

Multicare Pharmaceuticals Philippines is a Lupin Ltd. subsidiary and top-5 Philippine branded generics company distributing prescription medicines, OTCs, biosimilars and consumer health supplements across 12+ therapeutic areas via hospitals, three major retail pharmacy chains, government accounts, and Lazada/Shopee e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMakati, Philippines
HQ citystring
Makati
HQ countrystring
Philippines
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
branded generic pharmaceuticals, prescription medicines, over-the-counter products, consumer health supplements, pharmaceutical distribution
Industry3 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRAOAHAB
OTC Medicines & Consumer Health Products Distribution
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceuticals (Branded Generics)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Branded Generics
TypeOne Time License
Description

Revenue from branded generic pharmaceutical products across 12+ therapeutic segments including diabetes, oncology, neuroscience, gastroenterology, and anti-infectives.

multicare.com.ph
2OTC/Consumer Health Products
TypeOne Time License
Description

Over-the-counter products and multivitamins sold through retail pharmacies and e-commerce channels.

multicare.com.ph
3Prescription Medicines
TypeOne Time License
Description

Prescription pharmaceutical products including biosimilars and innovator products sold through hospitals, clinics, and retail pharmacies.

multicare.com.ph
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Multicare Pharmaceuticals Philippines manufactures, markets, and distributes a diversified portfolio of branded generic prescription medicines, over-the-counter (OTC) products, biosimilars, and consumer health supplements across 12+ therapeutic areas including diabetes, oncology, neuroscience, gastroenterology, anti-infectives, respiratory, rheumatology, critical care, women's health, and multivitamins. Products are commercialized in the Philippines through hospitals, retail pharmacy chains, government health programs, and e-commerce platforms under its own brand portfolio.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Nearly 5x growth since joining Lupin in 2009
+3 more records
Product overview1 text field

Multicare Pharmaceuticals Philippines is a pharmaceutical company offering a diversified portfolio of branded generic medicines, over-the-counter (OTC) products, prescription medicines, and consumer health supplements. The portfolio spans 12+ therapeutic areas including Diabetes (Glaritus, Lupigliptin, Lupigliptin Plus, Lupimet, Lupinsulin, Lupizin), Gastroenterology (Prazole Forte, Prazole I.V., Prazole Plus, Lupibile), Neuroscience (Motrigine, Morcet, Loxx, Lupiprine, Riscare), Oncology (Abingem, Cytobin, Doxocare, Cafonate, Naproplat, Naprocap, Pexate, Zildox, Taceedo, L-Aspase), Anti-Infectives (Cimex, Cimex Plus, Traxan, Triconex Forte), Respiratory (Neumoterol, Provexel NS, Provexel MDI, Multivent), Rheumatology (Coxicare, Furic, Binosto), Critical Care (Albutein, Gamunex-C, Plasbumin, Koate-DVI, Maxifer), Women's Health (Evaprost, Floracap), Consumer Health/Multivitamins (Calvit, Calvit Gold, Calprem, Mosvit Elite, Onima, Sorbifer Plus, Sorbifer Durules, Nausecare, Tamipro, Venocare), and Orthopedic/Pain Management (Pregmax M-75, Calprem). The company serves hospitals, retailers, government accounts, and e-commerce platforms (Lazada, Shopee) as part of its integrated multi-channel distribution strategy.

Product and service5 records
1ABINGEM 1G
CategoryPrescription Medicine (Oncology)
Description

Gemcitabine Hydrochloride 1g Lyophilized Powder for Injection, an oncology prescription medicine used for locally advanced or metastatic bladder cancer in combination with cisplatin, adenocarcinoma of the pancreas, and non-small cell lung cancer in combination with cisplatin.

2ALBUTEIN 20%
CategoryPrescription Medicine (Critical Care)
Description

Albumin 10g/50mL solution for critical care, used for emergency treatment of hypovolemic shock, burn therapy, hypoproteinemia, adult respiratory distress syndrome (ARDS), cardiopulmonary bypass, and acute liver failure.

3ALVEDON TABLET 500 MG
CategoryConsumer Health (OTC Analgesic)
Description

DC (Direct Compression) Paracetamol 500mg tablet, a consumer health product used for headache, toothache, fever associated with colds, menstrual pain, muscle pain, and flu.

4ANZOL 1 MG
CategoryPrescription Medicine (Oncology)
Description

Anastrozole 1mg Film-Coated Tablet, an oncology prescription medicine used for the treatment of breast cancer in postmenopausal women.

5ARILAN 5 MG
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

Multicare joined Lupin Ltd. in 2009 under the vision of Dr. Desh Bandhu Gupta. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. The partnership provides Multicare access to Lupin's 15 manufacturing sites, 7 research centers, and 24,000+ professionals globally.

2Bahay Aruga
Strategic tierMinorTypeOthers
Description

CSR partnership with Bahay Aruga, a complimentary halfway house in Ermita, Manila providing shelter for pediatric cancer patients undergoing outpatient treatment at PGH and nearby hospitals. Multicare has conducted outreach for 4 years delivering medicines and basic needs packs.

multicare.com.ph
Strategic tierMinorTypeOthers
Description

Partnership with Cancer Warrior Foundation to help young cancer patients in several South Luzon provinces through Multicare Pharma's nationwide CSR efforts.

Strategic tierMinorTypeOthers
Description

Partnership with BHOLI engaging youth in rebuilding efforts in Misamis Oriental as part of Multicare's nationwide community support programs.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

E-commerce platform partnership for online distribution of consumer health products including Sorbifer Plus, multivitamins, and other OTC products.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

E-commerce platform partnership for online distribution of consumer health products including Sorbifer Plus, multivitamins, and other OTC products.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Zuellig Pharma is the largest pharmaceutical distributor in the Philippines and serves as a logistics and channel partner for many of the same manufacturers and retailers that Multicare supplies directly, making it an adjacent ecosystem peer rather than a competing branded-generics manufacturer.

2Abbott Pharmaceuticals Philippines
TypeBroad incumbent
Description

Abbott Philippines sells prescription and consumer-health products across multiple therapeutic areas, including nutrition and OTC supplements, through the same retail-pharmacy chains (Watsons, Mercury Drug) and hospital channels used by Multicare.

TypeBroad incumbent
Description

Sanofi Philippines sells prescription and consumer-health products (including diabetes and vaccines) through the same retail-pharmacy and hospital channels as Multicare, making it a broad incumbent peer rather than a direct generics rival.

TypeBroad incumbent
Description

Merck Philippines sells prescription specialty and consumer-health products in oncology, fertility, and OTC supplements, competing for the same prescriber and pharmacist relationships as Multicare in hospitals and retail pharmacies.

TypeBroad incumbent
Description

AstraZeneca Philippines is the originator of the Astra Philippines division from which Multicare was spun off in 2002; it now competes in the same hospital and specialty-care channels in oncology, cardiovascular, and respiratory segments.

TypeBroad incumbent
Description

Bayer Philippines operates prescription and consumer-health franchises (cardiovascular, women's health, multivitamins) that overlap Multicare's Sorbifer, women's health, and cardiovascular offerings, with similar retail-pharmacy and e-commerce distribution.

TypeDirect peer
Description

Unilab is the largest pharmaceutical company in the Philippines and the dominant branded-generics player, making it the closest direct peer to Multicare's branded-generics, OTC, and consumer-health business across the same retail-pharmacy and hospital channels.

TypeBroad incumbent
Description

Novartis Philippines sells specialty and primary-care prescription medicines (including oncology and cardiology) through the same hospital and retail channels as Multicare, but as part of a global MNC portfolio rather than a Philippines-focused branded-generics specialist.

9GSK Philippines
TypeBroad incumbent
Description

GSK Philippines competes with Multicare in respiratory, vaccines, and consumer-health OTC categories through similar pharmacy and hospital channels, though as an MNC with global R&D rather than a Philippines branded-generics operator.

TypeBroad incumbent
Description

Pfizer Philippines operates across prescription, vaccines, and specialty care with broad hospital coverage that overlaps Multicare's oncology, anti-infectives, and primary-care segments, competing for the same prescriber mindshare.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Multicare Pharmaceuticals Philippines

Pharmaceuticals (Branded Generics)multicare.com.ph

Multicare Pharmaceuticals Philippines is a Lupin Ltd. subsidiary and top-5 Philippine branded generics company distributing prescription medicines, OTCs, biosimilars and consumer health supplements across 12+ therapeutic areas via hospitals, three major retail pharmacy chains, government accounts, and Lazada/Shopee e-commerce.

What Multicare Pharmaceuticals Philippines does

Multicare Pharmaceuticals Philippines, Inc. is a Makati City-based, privately-held pharmaceutical distributor and license holder serving the Philippine market as a wholly-owned subsidiary of India's Lupin Ltd. (since 2009). It was established in 1998 as a division of Astra Philippines Inc., became independent in 2002 under founder Romeo Sia Sy, and is positioned among the top 5 branded generic companies in the Philippines with 23+ years of operating history.

Its portfolio comprises prescription medicines, over-the-counter (OTC) consumer health products, biosimilars and innovator products across 12+ therapeutic areas: Diabetes, Oncology, Neuroscience, Gastroenterology, Anti-Infectives, Respiratory, Rheumatology, Critical Care, Women's Health, Orthopedic/Pain, Probiotic and Multi-Channel Consumer Health. Representative products include Glaritus (insulin glargine), Lupigliptin/Lupizin (oral antidiabetics), Abingem 1G and Anzol (oncology), Multivent and Neumoterol (respiratory), Albutein and Plasbumin (critical care plasma products), and consumer brands such as Sorbifer Plus, Calvit, Floracap and Tamipro. Manufacturing is not local; the company markets and distributes formulations via Lupin's global network of 15 manufacturing sites and 7 research centers, supplemented by licensing and business development.

The business model is a sales-led, multi-channel branded generics and consumer health franchise. Revenue is generated through one-time product sales across (i) direct field sales to hospitals and healthcare institutions, (ii) channel partnerships with the three major Philippine retail pharmacy chains (Watsons, Rose Pharmacy, Mercury Drug), (iii) government healthcare procurement, and (iv) e-commerce storefronts on Lazada and Shopee for OTC/consumer health. Pricing is not publicly disclosed; prescriber engagement, medical representatives, multi-channel consumer marketing, and Lupin-backed supply reliability are the stated value drivers.

Multicare Pharmaceuticals Philippines firmographics

Firmographics
Name
Multicare Pharmaceuticals Philippines
Legal name
Multicare Pharmaceuticals Philippines, Inc.
Website
https://multicare.com.ph
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
101–250 employees
Short description
Multicare Pharmaceuticals Philippines is a Lupin Ltd. subsidiary and top-5 Philippine branded generics company distributing prescription medicines, OTCs, biosimilars and consumer health supplements across 12+ therapeutic areas via hospitals, three major retail pharmacy chains, government accounts, and Lazada/Shopee e-commerce.
Ownership category
akta.pro rank

Multicare Pharmaceuticals Philippines industry classification

Industry
Product category
Pharmaceuticals (Branded Generics)
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRAOAHAB
OTC Medicines & Consumer Health Products Distribution

Keywords

  • Branded generic pharmaceuticals
  • Prescription medicines
  • Over-the-counter products
  • Consumer health supplements
  • Pharmaceutical distribution

Where Multicare Pharmaceuticals Philippines is headquartered

Location

Headquarters

HQ city
Makati
HQ country
Philippines
HQ region
Asia

Offices1 record

Markets served

Multicare Pharmaceuticals Philippines business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Branded Generics: Revenue from branded generic pharmaceutical products across 12+ therapeutic segments including diabetes, oncology, neuroscience, gastroenterology, and anti-infectives.
  2. OTC/Consumer Health Products: Over-the-counter products and multivitamins sold through retail pharmacies and e-commerce channels.
  3. Prescription Medicines: Prescription pharmaceutical products including biosimilars and innovator products sold through hospitals, clinics, and retail pharmacies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Multicare Pharmaceuticals Philippines product offering

Product offering

Core offering

Multicare Pharmaceuticals Philippines manufactures, markets, and distributes a diversified portfolio of branded generic prescription medicines, over-the-counter (OTC) products, biosimilars, and consumer health supplements across 12+ therapeutic areas including diabetes, oncology, neuroscience, gastroenterology, anti-infectives, respiratory, rheumatology, critical care, women's health, and multivitamins. Products are commercialized in the Philippines through hospitals, retail pharmacy chains, government health programs, and e-commerce platforms under its own brand portfolio.

Product overview

Multicare Pharmaceuticals Philippines is a pharmaceutical company offering a diversified portfolio of branded generic medicines, over-the-counter (OTC) products, prescription medicines, and consumer health supplements. The portfolio spans 12+ therapeutic areas including Diabetes (Glaritus, Lupigliptin, Lupigliptin Plus, Lupimet, Lupinsulin, Lupizin), Gastroenterology (Prazole Forte, Prazole I.V., Prazole Plus, Lupibile), Neuroscience (Motrigine, Morcet, Loxx, Lupiprine, Riscare), Oncology (Abingem, Cytobin, Doxocare, Cafonate, Naproplat, Naprocap, Pexate, Zildox, Taceedo, L-Aspase), Anti-Infectives (Cimex, Cimex Plus, Traxan, Triconex Forte), Respiratory (Neumoterol, Provexel NS, Provexel MDI, Multivent), Rheumatology (Coxicare, Furic, Binosto), Critical Care (Albutein, Gamunex-C, Plasbumin, Koate-DVI, Maxifer), Women's Health (Evaprost, Floracap), Consumer Health/Multivitamins (Calvit, Calvit Gold, Calprem, Mosvit Elite, Onima, Sorbifer Plus, Sorbifer Durules, Nausecare, Tamipro, Venocare), and Orthopedic/Pain Management (Pregmax M-75, Calprem). The company serves hospitals, retailers, government accounts, and e-commerce platforms (Lazada, Shopee) as part of its integrated multi-channel distribution strategy.

Differentiator

Problem solved

Functional benefit

Products and services

  • ABINGEM 1G Gemcitabine Hydrochloride 1g Lyophilized Powder for Injection, an oncology prescription medicine used for locally advanced or metastatic bladder cancer in combination with cisplatin, adenocarcinoma of the pancreas, and non-small cell lung cancer in combination with cisplatin.
  • ALBUTEIN 20% Albumin 10g/50mL solution for critical care, used for emergency treatment of hypovolemic shock, burn therapy, hypoproteinemia, adult respiratory distress syndrome (ARDS), cardiopulmonary bypass, and acute liver failure.
  • ALVEDON TABLET 500 MG DC (Direct Compression) Paracetamol 500mg tablet, a consumer health product used for headache, toothache, fever associated with colds, menstrual pain, muscle pain, and flu.
  • ANZOL 1 MG Anastrozole 1mg Film-Coated Tablet, an oncology prescription medicine used for the treatment of breast cancer in postmenopausal women.
  • ARILAN 5 MG

Quantifiable outcome

  • Nearly 5x growth since joining Lupin in 2009
  • +3 more outcomes

Companies that use Multicare Pharmaceuticals Philippines

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Multicare Pharmaceuticals Philippines technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Multicare Pharmaceuticals Philippines partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Lupin Ltd.coreStrategic or Co-development Partner · 1 January 2009Multicare joined Lupin Ltd. in 2009 under the vision of Dr. Desh Bandhu Gupta. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. The partnership provides Multicare access to Lupin's 15 manufacturing sites, 7 research centers, and 24,000+ professionals globally.
  • Bahay ArugaminorOthersCSR partnership with Bahay Aruga, a complimentary halfway house in Ermita, Manila providing shelter for pediatric cancer patients undergoing outpatient treatment at PGH and nearby hospitals. Multicare has conducted outreach for 4 years delivering medicines and basic needs packs.
  • Cancer Warrior FoundationminorOthersPartnership with Cancer Warrior Foundation to help young cancer patients in several South Luzon provinces through Multicare Pharma's nationwide CSR efforts.
  • BHOLI (Bridging Hopes & Opportunity Linkages Initiative)minorOthersPartnership with BHOLI engaging youth in rebuilding efforts in Misamis Oriental as part of Multicare's nationwide community support programs.
  • LazadaminorChannel Partner/ Reseller/ DistributorE-commerce platform partnership for online distribution of consumer health products including Sorbifer Plus, multivitamins, and other OTC products.
  • ShopeeminorChannel Partner/ Reseller/ DistributorE-commerce platform partnership for online distribution of consumer health products including Sorbifer Plus, multivitamins, and other OTC products.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Multicare Pharmaceuticals Philippines competitors and assessment

Company assessment

Others

  • Zuellig Pharma: Zuellig Pharma is the largest pharmaceutical distributor in the Philippines and serves as a logistics and channel partner for many of the same manufacturers and retailers that Multicare supplies directly, making it an adjacent ecosystem peer rather than a competing branded-generics manufacturer.

Broad incumbents

  • Abbott Pharmaceuticals Philippines: Abbott Philippines sells prescription and consumer-health products across multiple therapeutic areas, including nutrition and OTC supplements, through the same retail-pharmacy chains (Watsons, Mercury Drug) and hospital channels used by Multicare.
  • Sanofi Philippines: Sanofi Philippines sells prescription and consumer-health products (including diabetes and vaccines) through the same retail-pharmacy and hospital channels as Multicare, making it a broad incumbent peer rather than a direct generics rival.
  • Merck Philippines: Merck Philippines sells prescription specialty and consumer-health products in oncology, fertility, and OTC supplements, competing for the same prescriber and pharmacist relationships as Multicare in hospitals and retail pharmacies.
  • AstraZeneca Pharmaceuticals Philippines: AstraZeneca Philippines is the originator of the Astra Philippines division from which Multicare was spun off in 2002; it now competes in the same hospital and specialty-care channels in oncology, cardiovascular, and respiratory segments.
  • Bayer Philippines: Bayer Philippines operates prescription and consumer-health franchises (cardiovascular, women's health, multivitamins) that overlap Multicare's Sorbifer, women's health, and cardiovascular offerings, with similar retail-pharmacy and e-commerce distribution.
  • Novartis Philippines: Novartis Philippines sells specialty and primary-care prescription medicines (including oncology and cardiology) through the same hospital and retail channels as Multicare, but as part of a global MNC portfolio rather than a Philippines-focused branded-generics specialist.
  • GSK Philippines: GSK Philippines competes with Multicare in respiratory, vaccines, and consumer-health OTC categories through similar pharmacy and hospital channels, though as an MNC with global R&D rather than a Philippines branded-generics operator.
  • Pfizer Philippines: Pfizer Philippines operates across prescription, vaccines, and specialty care with broad hospital coverage that overlaps Multicare's oncology, anti-infectives, and primary-care segments, competing for the same prescriber mindshare.

Direct peers

  • Unilab (United Laboratories): Unilab is the largest pharmaceutical company in the Philippines and the dominant branded-generics player, making it the closest direct peer to Multicare's branded-generics, OTC, and consumer-health business across the same retail-pharmacy and hospital channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Multicare Pharmaceuticals Philippines social profiles

Digital presence

Multicare Pharmaceuticals Philippines compliance and trust

Trust signal

Compliance1 record

Multicare Pharmaceuticals Philippines financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Multicare Pharmaceuticals Philippines leadership team

Management profile

Number of profiles

Profiles1 record

Multicare Pharmaceuticals Philippines funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Multicare Pharmaceuticals Philippines M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multicare Pharmaceuticals Philippines

What does Multicare Pharmaceuticals Philippines do?

Multicare Pharmaceuticals Philippines manufactures, markets, and distributes a diversified portfolio of branded generic prescription medicines, over-the-counter (OTC) products, biosimilars, and consumer health supplements across 12+ therapeutic areas including diabetes, oncology, neuroscience, gastroenterology, anti-infectives, respiratory, rheumatology, critical care, women's health, and multivitamins. Products are commercialized in the Philippines through hospitals, retail pharmacy chains, government health programs, and e-commerce platforms under its own brand portfolio.

Is Multicare Pharmaceuticals Philippines a public or private company?

Multicare Pharmaceuticals Philippines is a private company. It is classified as corporate owned and is currently operating.

When was Multicare Pharmaceuticals Philippines founded?

Multicare Pharmaceuticals Philippines was founded in 1998. It employs 101 to 250 people.

Where is Multicare Pharmaceuticals Philippines based?

Multicare Pharmaceuticals Philippines is headquartered in Makati, Philippines, in the Asia region.

How does Multicare Pharmaceuticals Philippines make money?

Three revenue lines are on record. Branded Generics are the primary driver. The others are OTC/Consumer Health Products and prescription Medicines.

Who are Multicare Pharmaceuticals Philippines's main competitors?

Zuellig Pharma is listed as an others. Broad incumbents are Abbott Pharmaceuticals Philippines, Sanofi Philippines, Merck Philippines, AstraZeneca Pharmaceuticals Philippines, Bayer Philippines, Novartis Philippines, GSK Philippines and Pfizer Philippines. Unilab (United Laboratories) is listed as a direct peer.

Does Multicare Pharmaceuticals Philippines have an API?

No public API is recorded for Multicare Pharmaceuticals Philippines.

What industry is Multicare Pharmaceuticals Philippines in?

Multicare Pharmaceuticals Philippines's product category is Pharmaceuticals (Branded Generics). Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals